ОЦЕНКА ВЛИЯНИЯ ЭПИТРИАЗОЛИНА НА ФИЗИЧЕСКОЕ И ПСИХОЭМОЦИОНАЛЬНОЕ СОСТОЯНИЕ ПОДОПЫТНЫХ ЖИВОТНЫХ ПРИ ХРОНИЧЕСКОМ ВВЕДЕНИИ
Article Sidebar
Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.
Main Article Content
Аннотация:
В этой статье показано, что 4-(6-фенил-7H - [1,2,4] триазоло [3,4-B] [1,3,4] тиадиазин-3-ил) - анилин условно-Эпитриазолин у белых крыс 0,25; 2,5 и 25,0 мг/кг при пероральном приеме в течение 3 месяцев в зависимости от массы тела, цвета кожи, состояния шерсти, влияние на двигательную и исследовательскую активность в методе “открытое поле”, противотревожную активность подтверждена экспериментальными данними, и мы можем сказать, что побочные эффекты не проявляются при хроническом введении.
Article Details
Как цитировать:
Библиографические ссылки:
Shakirullah N. Ali., Khan A., Nabi M., The Prevalence, incidence and etiology of epilepsy. International Journal of Clinical and Experimental Neurology 2 (2014) 29–39.
Aurlien D., Gjerstad L., Taubøll E. The role of antiepileptic drugs in sudden unexpected death in epilepsy. Seizure 43 (2016) 56–60.
Rahimboev S. D., (2024). Neuropsychotropic activity of 1,2,4-triazole derivatives. Oriental Journal of Medicine and Pharmacology, 4(05), 12–26. https://doi.org/10.37547/supsci-ojmp-04-05-02
Rahimboyev S.D., at all. (2025). 5-(p-aminofenil)-4-amino-1,2,4-triazol-3(2H)-tionning o‘tkir zaharliligi va tutqanoqqa qarshi faolligi. Евразийский журнал медицинских и естественных наук, 5(2 Part 2), 110–118. извлечено от https://in-academy.uz/index.php/EJMNS/article/view/46508
Rahimboev S. D., Sanoev Z. I., Khamroyev T. T., Abdinazarov I. T., Rashidov S. Z., Ismoilova D. S., & Elmuradov B. (2025). Safety assessment of the 4- (6-phenyl-7H - [1,2,4] triazolo [3,4-b] [1,3,4] thiadiazine-3-yl) -aniline compound and the effects of the substance on respiration and cardiac activity. American Journal Of Biomedical Science & Pharmaceutical Innovation, 5(03), 19–24. https://doi.org/10.37547/ajbspi/Volume05Issue03-05
Sanoev, Z. I., Ismailova, D. S., Rakhimboev, S. D., Tolibovich, T. T., Elmuradov, B. J., Abdinazarov, I. T., & Rashidov, S. Z. (2023). Synthesis And Research Anticonvulsant Activity Of Annulated Triazolo-thiadiazine Derivative In Laboratory Animals. Biomedical & Pharmacology Journal, 16(4), 2457-2467.
Wingrove P.B., Wafford K.A., Bain C., Whiting P. J. The modulatory action of loreclezole at the gamma-aminobutyric acid type A receptor is determined by a single amino acid in the beta 2 and beta 3 subunit. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 4569–4573.
Plech. T., Łuszczki J.J., Wujec M., Flieger J., Pizoń M. Synthesis, characterization and preliminary anticonvulsant evaluation of some 4-alkyl-1,2,4-triazoles. Eur J Med Chem 2013, 60, 208-215.
Plech T., Kaproń B., Łuszczki J.J., at. all. Studies on the anticonvulsant activity of 4-alkyl-1,2,4-triazole-3-thiones and their effect on gabaergic system. Eur J Med Chem 2014, 86, 690-699.
Kaproń B., Łuszczki J., Paneth, A., at. all. Molecular mechanism of action and safety of 5-(3-chlorophenyl)-4-hexyl-2,4-dihydro-3H-1,2,4-triazole-3-thione – a novel anticonvulsant drug candidate. Int J Med Sci 2017, 14, 741-749.
Kaproń, B., Łuszczki J.J., Płazińska A., at. all. Development of the 1,2,4-triazole-based anticonvulsant drug candidates acting on the voltage-gated sodium channels. Insights from in-vivo, in-vitro, and in-silico studies. Eur J Pharm Sci 2019, 129, 42-57.
Kaproń B., Łuszczki J., Paneth A., at. all. Molecular mechanism of action and safety of 5-(3-chlorophenyl)-4-hexyl-2,4-dihydro-3H-1,2,4-triazole-3-thione – a novel anticonvulsant drug candidate. Int J Med Sci 2017, 14, 741-749.
Łuszczki J.J., Marzęda P., Gut-Lepiech A., at. all. New derivative of 1,2,4-triazole-3-thione (TP427) potentiates the anticonvulsant action of valproate, but not that of carbamazepine, phenytoin or phenobarbital in the mouse tonic-clonic seizure model. Pharmacol Rep 2019, 71, 299-305.
Султонов, С. А. (2024). Оценка нейротропной активности синтетических гетероциклических соединений (обзор литературы). Re-health journal, (4 (24)), 33-38.
Rakhimboev, S. D., at all. (2022). Screening study of neurotropic properties of new triazole derivative. Oriental Journal of Medicine and Pharmacology, 2(04), 12-20.
Rakhimboev S.D., at all. (2022). Screening Study of the Anxiolytic Activity of New Triazole Compounds. Texas Journal of Medical Science, 13, 43–46. https://doi.org/10.62480/tjms.2022.vol13.pp43-46
Yaribeygi H, Panahi Y, Sahraei H, Johnston TP, Sahebkar A. The impact of stress on body function: A review. EXCLI J. 2017 Jul 21;16:1057-1072. doi: 10.17179/excli2017-480. PMID: 28900385; PMCID: PMC5579396.
Magdalena Białońet al. 1MeTIQ and olanzapine, despite their neurochemical impact, did not ameliorate performance in fear conditioning and social interaction tests in an MK-801 rat model of schizophrenia. Pharmacol Rep. 2021 Jan 6.doi: 10.1007/s43440-020-00209-9.
Agnieszka Wąsik, Irena Romańska, Agnieszka Zelek-Molik, Lucyna Antkiewicz-Michaluk. Multiple Administration of Endogenous Amines TIQ and 1MeTIQ Protects Against a 6-OHDA-Induced Essential Fall of Dopamine Release in the Rat Striatum: In Vivo Microdialysis Study. Neurotox Res. 2018 Apr;33(3):523-531.doi: 10.1007/s12640-017-9824-8.Epub 2017 Oct 26.
Lucyna Antkiewicz-Michaluket al. The mechanism of 1,2,3,4-tetrahydroisoquinolines neuroprotection: the importance of free radicals scavenging properties and inhibition of glutamate-induced excitotoxicity. J Neurochem. doi: 10.1111/j.1471-4159.2006.03756.x.Epub 2006 Mar 3.
E. Możdżeń et al. 1,2,3,4-Tetrahydroisoquinoline produces an antidepressant-like effect in the forced swim test and chronic mild stress model of depression in the rat: Neurochemical correlates/ European Journal of Pharmacology 729 (2014) 107–115
E. Możdżeń et al. Antidepressant-like effect of 1,2,3,4-tetrahydroisoquinoline and its methyl derivative in animal models of depression. Pharmacological Reports. PubDate2017-02-08, DOI:10.1016/j.pharep.2017.01.032
Sanoev Z.I., Mirzaev Yu.R. Pharmacological Activity Of The Possessing New Atypical Neuroleptics 1-Phenyltetrahydroisoquinoline Structure. The American Journal of Medical Sciences and Pharmaceutical Research Published: 2020|Pages:18-26 https://doi.org/10.37547/TAJMSPR/Volume02Issue08-03
Sanoev Z.I., Mirzaev Y.R. Research of a new atypical neuroleptic 1-(3,4,-methylenedioxyphenyl)-6,7-methylenedioxy-1,2,3,4-tetrahydroisoquinoline on the central nervous system. Annals of the Romanian Society for Cell Biology, 2021, 25 (2), 2363–2369
Мирзаев Ю. Р., Саноев З. И., Жўрақулов Ш. Н., & Виноградова В. И. (2015). Психофармакологические свойства производного тетрагидроизохинолина. Международный научный журнал “Unity of Science” Вена, Австрия, 170-174.
Sanoev, Z. I. (2020). Skimmianine-a promising antidepressant among furanoquinoline alkaloids. Journal of Biomedicine and Practice, 751-757.
European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes, ETS No123, Strasbourg (1986).
Миронов А.Н. Руководство по проведению доклинических исследований лекарственных средств. Часть первая. – М.: Гриф и К, 2012. -944 с.
Strelkov R.B. Statistical data for accelerated quantitative assessment of pharmacological effect. Pharmacology and Toxicology 1986. No. 4 p.100-104.
Isomiddinovich, S. Z., Rahmanovich, M. Y., Karimdjanovna, Y. L., Furqatovna, R. N., Bahodirovich, P. O., & Po’latovich, B. B. (2021). Toxicological Characteristics Of Skimmianine Under Chronic Administration In White Rats. European Journal of Molecular & Clinical Medicine, 8(02), 2021.
Lola Tishaevna Zakhidova, Dilfuza Mir-Takhirovna Saidkhodjaeva, Tolmas Tolibovich Khamroev, Zafar Isomiddinovich Sanoev, Visola Farmanovna Tukhtasheva, & Hilola Akhmedjanovna Rakhmanova. (2021). Toxicological Characteristics Of N-Deacetyllappaconitine Under Chronic Administration In White Rats. The American Journal of Applied Sciences, 3(3), 34–41. https://doi.org/10.37547/tajas/Volume03Issue03-06
Саноев Зафар Исомиддинович, & Якубова Лутфия Каримжоновна (2018). Исследование эмбриотоксичности и тератогенности главного алкалоида Arundo donax донаксина. Наука, техника и образование, (1 (42)), 51-55.